Quantcast

Latest kidney diseases Stories

2014-03-25 08:29:32

LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, and the Alport Syndrome Foundation ("ASF"), a non-profit corporation, announced today they are working together to raise awareness of Alport Syndrome, a life-threatening genetic kidney disease driven by genetic mutations with no approved therapy. This month, Regulus will join the...

2014-03-24 16:24:57

RIVER EDGE, N.J., March 24, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the successful completion of its rights offering. Nephros received gross proceeds of $2.14 million from the rights offering. A portion of the proceeds was used for the repayment of...

2014-03-21 23:22:34

An increased risk of bladder cancer may not be the only disease risk for people treated with the diabetes drug Actos. Raleigh, NC (PRWEB) March 21, 2014 Cancer Monthly is reporting on new research published by PLoS One suggesting that the diabetes drug Actos, which is already associated with an increased risk of bladder cancer, may also increase the risk of developing chronic kidney disease. Actos (pioglitazone) is in a class of drugs called thiazolidinediones and has been administered...

2014-03-20 12:29:52

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022 EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022SummaryChronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function over time. CKD affects people of all ages; however, the risk is higher in...

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2014-03-18 08:31:30

DENVER, March 18, 2014 /PRNewswire/ -- DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, celebrates its more than 3,000 social worker and dietitian teammates during the entire month of March. March is National Kidney Month and also marks both National Social Work Month and National Nutrition Month, recognizing the important roles of dietitians and social workers in kidney care. These teammates provide specialized...

2014-03-15 23:04:14

Kidney Stone Removal Report is the latest program developed by Joe Barton, who promises to help people treat their kidney stones quickly. An overview on the website Vinaf.com shows if the program is good for people to use. Tampa, FL (PRWEB) March 15, 2014 Kidney Stone Removal Report developed by Joe Barton is a new program that introduces to people a lot of exercises, methods, and step-by-step instructions on how to treat their kidney stones. In the program, people will discover how to...

2014-03-12 20:24:20

HAYWARD, Calif., March 12, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended December 31, 2013. Fourth Quarter and Fiscal Year 2013 Financial Results: Net loss for the fourth quarter and year ended December 31, 2013 was $9.2 million and $30.9 million, respectively. Operating expense for the year ended December 31, 2013 was $28.2 million as compared to $55.9 million for...

2014-03-11 16:26:49

RIVER EDGE, N.J., March 11, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration system for the treatment of chronic renal failure patients today provided an update on its operations and strategy. Recent Highlights -- Daron Evans appointed to Board of Directors -- Launched NanoGuard-D and NanoGuard-S ultrafilters for filtration of water...

2014-03-11 08:28:37

World Kidney Day Event to Discuss Building Global Awareness of Kidney Disease DENVER, March 11, 2014 /PRNewswire/ -- DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, will host a Google+ Hangout on Air dedicated to global kidney disease awareness on World Kidney Day. Join the "Be #KidneyAware: Raise Kidney Disease Awareness Worldwide" Google+ Hangout on Air on Thursday, March 13, at 8:30 a.m. PT/11:30 a.m. ET by registering at...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related